POST Online Media Lite Edition



 

NEWLY REPORTED COVID-19 CASES IN LAST 24 HOURS (9.24.2021, 6:35pm CEST, WHO):   U.S. 121,396    India 31,382    Brazil 36,473    United Kingdom 35,764    Russia 21,379    Turkey 27,844    France 5,433    Argentina 2,034    Columbia 1,581    Spain 1,056    Italy 4,053    Indonesia 2,557    Germany 9,727    Mexico 11,603    South Africa 2,783    Philippines 17,411    Ukraine 9,058    Malaysia 13,754    Netherlands 1,841    Iraq 2,953    Japan 3,457    Canada 3,870    Bangladesh 1,233    Thailand 12,697    Israel 6,314    Pakistan 2,357    Romania 7,116    Serbia 6,480    Cuba 6,935    Nepal 1,103    Vietnam 9,472    Austria 1,708    Greece 2,101    Georgia 1,698    Belarus 1,973    Costa Rica 2,547    Bulgaria 1,835    Azerbaijan 1,178    Myanmar 1,667    Croatia 1,291    Ireland 1,354    Venezuela 1,140    Ethiopia 1,544    Libya 1,006    Lithuania 1,477    South Korea 2,434    Mongolia 2,612    Slovenia 1,011    Moldova 1,215    Botswana 2,639    New Caledonia 1,078    China 65    Singapore 1,504    New Zealand 10    Australia 1,850   

Sinovac launches clinical trial of COVID-19 vaccine on children, teenagers in South Africa

Christian Fernsby |
Chinese pharmaceutical company Sinovac Biotech on Friday launched the Phase III clinical trial of its COVID-19 vaccine on a group of children and teenagers between six months and 17 years old in South Africa.

Article continues below




The study, carried out in collaboration with South African company Numolux Group, has enrolled approximately 2,000 participants in the country, who will receive two doses of Sinovac's CoronaVac vaccine or a placebo, 28 days apart. The efficacy assessment will be based on relevant indicators.

Numolux CEO Hilton Klein said that there are roughly 24 million children and teenagers in South Africa, and that if the vaccine made by Sinovac is approved for use on them, it will help the country reach herd immunity more quickly.

The South African Health Products Regulatory Authority authorized the use of the CoronaVac vaccine on the country's adults in July.


What to read next

China approves Sinovac vaccine for use in 3-17-year-olds
New vaccine to provide 2-year protection
World-first COVID-19 alternating dose vaccine study launches in UK